Genes in panel
STRs in panel
Prev Next

Genetic epilepsy syndromes

Gene: TSC1

Green List (high evidence)

TSC1 (TSC complex subunit 1)
EnsemblGeneIds (GRCh38): ENSG00000165699
EnsemblGeneIds (GRCh37): ENSG00000165699
OMIM: 605284, Gene2Phenotype
TSC1 is in 25 panels

5 reviews

Rebecca Foulger (Genomics England curator)

I don't know

Review and rating collated by Tracy Lester (Oxford Medical Genetics Laboratories Oxford University Hospitals NHS Foundation Trust, 2019_02_06) on behalf of Wessex and West Midlands GLH for GMS Neurology specialist test group, for Clinical Indication R59 'Early onset or syndromic epilepsy'. Review contributors: John Taylor and Helen Lord. Suggested gene rating: Green.
Created: 6 Aug 2019, 8:38 p.m. | Last Modified: 6 Aug 2019, 8:38 p.m.
Panel Version: 1.189

Tracy Lester (Genetics laboratory, Oxford UK)

Green List (high evidence)

AD Tuberous Sclerosis type 1 - multisystem disorder which does include seizures/epilepsy (more than 80% on gene reviews).
Created: 6 Aug 2019, 8:31 p.m. | Last Modified: 6 Aug 2019, 8:31 p.m.
Panel Version: 1.188

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Tuberous sclerosis-1, 191100

Publications

Zornitza Stark (Australian Genomics)

Green List (high evidence)

The association of somatic variants and focal cortical dysplasia notwithstanding, seizures are a very common feature of tuberous sclerosis.
Created: 22 Aug 2018, 7:02 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Tuberous sclerosis-1, MIM#191100

Variants in this GENE are reported as part of current diagnostic practice

Sarah Leigh (Genomics England Curator)

Seizures reported in both Focal cortical dysplasia, type II, somatic 607341; Tuberous sclerosis-1 191100. Some reports of mosaicism in Tuberous sclerosis-1 (PMID 10053179).
Green rating for this gene supported by the opinions of Genomics England clinical fellows, Helen Britain and Anna de Burca.
Created: 9 Apr 2018, 2:53 p.m.
Comment on phenotypes: Seizures reported in both phenotypes
Created: 9 Apr 2018, 2:31 p.m.

Ellen McDonagh (Genomics England Curator)

A missense variant was originally reported in PMID: 12112044 but this has been reclassified in OMIM as a variant of unknown significance due to the gene-disease association having been refuted by PMID:19175396 which reported sequence alterations in the TSC1 and TSC2 genes in lesional brain tissue and blood of Focal cortical dysplasia patients are found in a similar frequency to that of a normal population. A more recent publication (PMID: 28215400) provides more evidence for somatic brian mutations in TSC1 and TSC2 to be implicated in FCD2. They took 40 patients who were negative for MTOR mutations, and found candidate causative somatic brian variants in TSC1 or TSC2 in 5 patients (3 different missense variants). In vitro assays provided evidence to show that the mutations induced activation of mTOR kinase by disturbing the formation or function of the TSC1-TSC2 complex. Using in utero CRISPR-Cas9 somatic genome-editing system, a focal cortical disruption of the TSC1-TSC2 complex, encoded by Tsc1 and Tsc2 was reported to cause spontaneous behavioral seizures as well as migration defects and cytomegalic neurons, consistent with the neuropathological phenotype of individuals with FCD2. Two of the 3 variants reported were found at a low frequency in ExAC Browser (1.65x10-5 and 3.34x10-5).
Created: 22 Sep 2017, 2:54 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Focal cortical dysplasia, type II, somatic 607341

Publications

History Filter Activity

6 Aug 2019, Gel status: 3

Added New Source

Rebecca Foulger (Genomics England curator)

Source Wessex and West Midlands GLH was added to TSC1.

6 Aug 2019, Gel status: 3

Added New Source

Rebecca Foulger (Genomics England curator)

Source NHS GMS was added to TSC1.

11 Dec 2018, Gel status: 3

Panel promoted to version 1.0

Sarah Leigh (Genomics England Curator)

Ellen McDonagh: A missense variant was origina

7 Nov 2018, Gel status: 3

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: tsc1 has been classified as Green List (High Evidence).

26 Sep 2018, Gel status: 2

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: tsc1 has been classified as Amber List (Moderate Evidence).

25 Jun 2018, Gel status: 2

Added New Source

Sarah Leigh (Genomics England Curator)

Victorian Clinical Genetics Services was added to TSC1. Panel: Genetic Epilepsy Syndromes

9 Apr 2018, Gel status: 2

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for TSC1 were set to Focal cortical dysplasia, type II, somatic 607341; Tuberous sclerosis-1 191100

4 Apr 2018, Gel status: 2

Added New Source

Sarah Leigh (Genomics England Curator)

TSC1 was added to Genetic Epilepsy Syndromes panel. Sources: Literature,Expert Review Amber

4 Apr 2018, Gel status: 2

Created

Sarah Leigh (Genomics England Curator)

TSC1 was created by Sarah Leigh